Christensen et al developed a discriminant function for evaluating a patient with fulminant hepatic failure. This can help identify a patient who may require more aggressive management. The authors are from the University of Copenhagen.
NOTE: This represents the reduced score in Table IV. A complete score is in Table III.
Parameters:
(1) age in years
(2) gender
(3) duration of history in days
(4) hepatitis B status
(5) disulfiram hepatitis
(6) prothrombin index in units
(7) serum albumin in µmol/L
(8) serum potassium in mmol/L
(9) blood glucose in mmol/L
(10) leukocyte count in 10^9/L
(11) blood group
Parameter |
Finding |
Points |
gender |
male |
1 |
|
female |
0 |
hepatitis B status |
absent |
0 |
|
present |
1 |
disulfiram hepatitis |
absent |
0 |
|
present |
1 |
blood group |
Type O |
1 |
|
other (A, B, AB) |
0 |
where:
• The prothrombin index has a reference range of 0.7 to 1.3. Patients tended to have values below 0.5.
• The molecular weight of albumin is around 66,460 daltons. 1 g/dL equals 150.5 µmol/L.
score =
= (0.015 * (age in years)) - (0.27 * (points for gender)) + (0.0081 * (number of days)) + (0.31 * (points for hepatitis B)) + (0.83 * (points for disulfiram)) - (1.28 * (prothrombin index)) - (0.0019 * (serum albumin in µmol/L)) + (0.12 * (potassium in mmol/L)) + (0.089 * (glucose in mmol/L)) + (0.032 * (leukocyte count in 10^9/L)) - (0.25 * (points for blood group)) - 0.45
Discriminant Score |
Posterior Probability of Survival |
< 0 |
100% |
0 - 0.25 |
> 90% |
0.5 |
50% |
0.75 - 1.0 |
< 10% |
> 1.0 |
0% |
from Figure 2, page 95 (Christensen et al)
where:
• The posterior probability of survival is affected by the prior probability.
Limitations:
• The outcome prediction is based on care in 1984.
Purpose: To evaluate a patient with fulminant hepatitis using the discriminant score of Christensen et al.
Specialty: Gastroenterology
Objective: other testing, severity, prognosis, stage, selection
ICD-10: K72.0,